Drug Profile
NBP 608
Alternative Names: NBP608; Skyzoster; SKYZosterLatest Information Update: 11 Jan 2023
Price :
$50
*
At a glance
- Originator SK Chemicals
- Developer SK Bioscience
- Class Attenuated vaccines; Varicella vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Herpes zoster
- No development reported Varicella zoster virus infections
Most Recent Events
- 09 Jan 2023 Registered for Herpes zoster (Prevention) in Malaysia (SC)
- 09 Jan 2023 Adverse events and immunogenicity data from a phase-III trial in Herpes zoster released by SK bioscience
- 23 Feb 2022 No development reported - Phase-III for Varicella zoster virus infections (In children, In infants, Prevention) in Philippines (SC)